SCHEMBL3294683

SCHEMBL3294683

Cc1c(-c2ccccc2)c(N2CC[C@H](N(C)C)C2)c2oc(N(C)CCC(=O)O)nc2c1C#N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPEPLD Q6IQ20 1/20 0.36
MCHR1 Q99705 5/20 0.36
CTSL P07711 1/20 0.34
CTSB P07858 1/20 0.34
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
KHK P50053 1/20 0.34
HTR1D P28221 2/20 0.34
HTR3A P46098 2/20 0.34
HTR6 P50406 2/20 0.34
TMEM97 Q5BJF2 2/20 0.34
MAPK8 P45983 2/20 0.34
BTK Q06187 2/20 0.34
MRGPRX2 Q96LB1 2/20 0.34
HTR1A P08908 1/20 0.34
DRD2 P14416 1/20 0.34
HTR1B P28222 1/20 0.34
SLC6A3 Q01959 1/20 0.34
ADRA1B P35368 1/20 0.34
HRH3 Q9Y5N1 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4797542 0.91 HTR1D (0.35) NAPEPLDMCHR1HTR1DHTR3AHTR6
SCHEMBL3295132 0.91 NAPEPLD (0.33) NAPEPLDMCHR1CTSLCTSBCTSS
SCHEMBL3295299 0.88 MCHR1 (0.36) MCHR1CTSLCTSBCTSSCTSK
SCHEMBL3294284 0.87 MCHR1 (0.36) NAPEPLDMCHR1CTSLCTSBCTSS
SCHEMBL3294469 0.87 HTR1D (0.39) MCHR1HTR1DHTR3AHTR6TMEM97
SCHEMBL3295259 0.86 MCHR1 (0.35) NAPEPLDMCHR1CTSLCTSBCTSS
SCHEMBL3293401 0.86 HTR1D (0.37) MCHR1HTR1DHTR3AHTR6TMEM97
SCHEMBL3299085 0.85 MCHR1 (0.35) MCHR1CTSLCTSBCTSSCTSK
SCHEMBL3322066 0.85 MCHR1 (0.35) NAPEPLDMCHR1CTSLCTSBCTSS
SCHEMBL3297561 0.85 HTR1D (0.37) MCHR1HTR1DHTR3AHTR6TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737166-B2 Antifungal bicyclic hetero ring compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-06-15 US disclosed
US-20090143353-A1 such as 2-tert-Butyl-7-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-5-methyl-6-phenyl-1,3-benzoxazole-4-carbonitrile hydrochloride, a 1,6-beta-glucan synthetase inhibitor having potent growth inhibition, used treating a fungal infections; fungicides DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-06-04 US disclosed
EP-1932837-A1 BICYCLO HETEROCYCLIC COMPOUND HAVING ANTIFUNGAL ACTION Daiichi Sankyo Company, Limited (JP) 2008-06-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143353-A1 such as 2-tert-Butyl-7-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-5-methyl-6-phenyl-1,3-benzoxazole-4-carbonitrile hydrochloride, a 1,6-beta-glucan synthetase inhibitor having potent growth inhibition, used treating a fungal infections; fungicides CTPS1, TPP1, STS NAPEPLD 4358/4885MCHR1 4162/4885CTSL 1324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.